Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety
| Autor: | Matulonis, U.A. *, Penson, R.T., Domchek, S.M., Kaufman, B., Shapira-Frommer, R., Audeh, M.W., Kaye, S., Molife, L.R., Gelmon, K.A., Robertson, J.D., Mann, H., Ho, T.W., Coleman, R.L. |
|---|---|
| Zdroj: | In Annals of Oncology June 2016 27(6):1013-1019 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|